Avidity Partners Management LP
- SEC CIK
- 0001791827
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 45
- 0 vs. Q1 2026
- Portfolio value
- $624.4M
- +$130.6M (+26.5%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. | COM | 2,104,184 | $205.1M | 32.8% | 00.0% | Unchanged | History |
| CGONCG Oncology, Inc. | COM | 1,398,948 | $99.4M | 15.9% | +110,000+8.5% | Added | History |
| ORKAOruka Therapeutics, Inc. | COM | 760,424 | $72.4M | 11.6% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM NEW | 1,700,708 | $37.8M | 6.1% | +300,000+21.4% | Added | History |
| ELVNEnliven Therapeutics, Inc. | COM | 550,000 | $27.9M | 4.5% | +150,000+37.5% | Added | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 6,299,999 | $21.5M | 3.4% | +250,000+4.1% | Added | History |
| AKTSAktis Oncology, Inc. | COM | 484,200 | $15.6M | 2.5% | +15,634+3.3% | Added | History |
| PVLAPalvella Therapeutics, Inc. | COM | 70,000 | $10.7M | 1.7% | 00.0% | Unchanged | History |
| MOBIMobia Medical, Inc. | COMMON STOCK | 798,282 | $10.7M | 1.7% | +798,282 | New | History |
| RGENRepligen Corp | COM | 77,800 | $10.6M | 1.7% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM NEW | 669,941 | $10.3M | 1.6% | 00.0% | UnchangedConverted for a 1-for-10 split | History |
| SENSSenseonics Holdings, Inc. | COM | 1,600,000 | $9.09M | 1.5% | +1,600,000 | New | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 924,487 | $9.03M | 1.4% | +460,746+99.4% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 200,000 | $6.78M | 1.1% | −250,100−55.6% | Reduced | History |
| DXCMDexcom Inc | COM | 100,000 | $6.74M | 1.1% | +10,000+11.1% | Added | History |
| TEMTempus AI, Inc. | CL A | 105,000 | $6.08M | 1.0% | +80,000+320.0% | Added | History |
| MDTMedtronic plc | Stock | 70,000 | $5.48M | 0.9% | −30,000−30.0% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 519,300 | $5.29M | 0.8% | −430,700−45.3% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 98,000 | $5.26M | 0.8% | +68,000+226.7% | Added | History |
| EHCEncompass Health Corp | COM | 42,000 | $4.25M | 0.7% | 00.0% | Unchanged | History |
| TENXTenax Therapeutics, Inc. | COM NEW | 265,934 | $3.87M | 0.6% | +50,000+23.2% | Added | History |
| NVCTNuvectis Pharma, Inc. | COM | 200,000 | $3.68M | 0.6% | +200,000 | New | History |
| PODDInsulet Corp | Stock | 24,000 | $3.65M | 0.6% | +24,000 | New | History |
| BSXBoston Scientific Corp | Stock | 80,000 | $3.41M | 0.5% | +20,000+33.3% | Added | History |
| MSLESatellos Bioscience Inc. | COM | 387,769 | $3.01M | 0.5% | 00.0% | Unchanged | History |
| ALMRAlamar Biosciences, Inc. | COMMON STOCK | 110,000 | $2.98M | 0.5% | +110,000 | New | History |
| CNTXContext Therapeutics Inc. | COM | 4,998,267 | $2.77M | 0.4% | 00.0% | Unchanged | History |
| GILDGilead Sciences, Inc. | Stock | 20,000 | $2.53M | 0.4% | 00.0% | Unchanged | History |
| CRLCharles River Laboratories International, Inc. | COM | 10,000 | $2.27M | 0.4% | +10,000 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 200,000 | $2.17M | 0.3% | −49,390−19.8% | Reduced | History |
| AVLNAvalyn Pharma Inc. | COM SHS | 60,000 | $1.98M | 0.3% | +60,000 | New | History |
| KLRAKailera Therapeutics, Inc. | COMMON STOCK | 80,000 | $1.76M | 0.3% | +80,000 | New | History |
| GMABGenmab A/S | SPONSORED ADS | 50,000 | $1.37M | 0.2% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 75,000 | $1.27M | 0.2% | 00.0% | Unchanged | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 80,000 | $1.20M | 0.2% | −35,000−30.4% | Reduced | History |
| ODDOddity Tech Ltd | SHS CL A | 70,000 | $1.06M | 0.2% | 00.0% | Unchanged | History |
| SCYXScynexis Inc | COM | 260,206 | $1.06M | 0.2% | 00.0% | UnchangedConverted for a 1-for-8 split | History |
| EVMNEvommune, Inc. | COM SHS | 75,000 | $996.8K | 0.2% | +75,000 | New | History |
| ABTAbbott Laboratories | Stock | 10,000 | $907.4K | 0.1% | +10,000 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 10,000 | $744.8K | 0.1% | +10,000 | New | History |
| PTONPeloton Interactive, Inc. | CL A COM | 100,000 | $591.0K | 0.1% | −100,000−50.0% | Reduced | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 15,000 | $433.2K | 0.1% | +15,000 | New | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 43,853 | $334.2K | 0.1% | 00.0% | Unchanged | History |
| SVRASavara Inc | COM | 50,000 | $308.0K | <0.1% | +50,000 | New | History |
| TRVITrevi Therapeutics, Inc. | COM | 6,660 | $124.2K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (13)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| CNCCentene Corp | Stock | 70,000 | $2.29M | 0.5% | History |
| NTRANatera, Inc. | COM | 9,000 | $1.80M | 0.4% | History |
| ICLRIcon PLC | COM | 16,000 | $1.77M | 0.4% | History |
| KVUEKenvue Inc. | Stock | 100,000 | $1.72M | 0.3% | History |
| HIMSHims & Hers Health, Inc. | Stock | 75,000 | $1.56M | 0.3% | History |
| RVMDRevolution Medicines, Inc. | COM | 15,000 | $1.46M | 0.3% | History |
| CORTCorcept Therapeutics Inc | COM | 30,000 | $1.21M | 0.2% | History |
| ABVXAbivax S.A. | SPONSORED ADS | 10,000 | $1.11M | 0.2% | History |
| UNHUnitedHealth Group Inc | Stock | 3,800 | $1.03M | 0.2% | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 50,000 | $932.0K | 0.2% | History |
| AVRAnteris Technologies Global Corp. | COM | 150,000 | $832.5K | 0.2% | History |
| ABUSArbutus Biopharma Corp | COM | 125,000 | $562.5K | 0.1% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 12,967 | $288.6K | 0.1% | History |